Description:NaturalcannABInoid;GPR55antagoNIST,weakCB1antagonist,CB2inverseagonistandAMTinhibitorAlternativeNames:CBDChemicalName:2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediolPurity:≥98%(HPLC)BIOLOGicalActivityTechnicalDataSolubilityCalculatorsDatasheetsReferencesBiologicalActivityNon-psychotropicconstituentofcannabisthatisanticonvulsive,antihyperalgesicandneuroprotectiveinvivo.GPR55andweakCB1antagonist(IC50valuesare0.445and3.35μM),CB2receptorinverseagonistandinhibitorofanandamideuptake(IC50=27.5μM).AlsoaweakagonistatVR1vanilloidreceptors(EC50=3.5μM).TechnicalDataM.Wt314.47FormulaC21H30O2StorageStoreat-20°CPurity≥98%(HPLC)CASNumber13956-29-1PubChemID12302390InChIKeyQHMBSVQNZZTUGM-ROUUACIJSA-NSmilesCCCCCC1=CC(O)=C([C@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.AllTocrisproductsareintendedforlaboratoryresearchuseonly.SolubilityDataSolventMaxConc.mg/mLMaxConc.mMSolubilityDMSO23.5975ethanol23.5975PreparingStockSolutionsThefollowingdataisbasedontheproductmolecularweight314.47.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.Concentration/SolventVolume/Mass1mg5mg10mg1mM3.18mL15.9mL31.8mL5mM0.64mL3.18mL6.36mL10mM0.32mL1.59mL3.18mL50mM0.06mL0.32mL0.64mLMolarityCalculatorMolarityCalculatorCalculatethemass,volume,orconcentrationrequiredforasolution.ReconstitutionCalculatorReconstitutionCalculatorDilutionCalculatorDilutionCalculatorCalculatethedilutionrequiredtoprepareastocksolution.ProductDatasheetsCertificateofAnalysis/ProductDatasheetSafetyDatasheetSelectanotherlanguage:EnglishGermanFrenchSpanishViewSDSReferencesReferencesarepublicationsthatsupporttheproducts'biologicalactivity.Costaetal(2004)VanilloidTRPV1receptormediatestheantihyperalgesiceffectofthenonpsychoactivecannabinoid,cannabidiol,inaratmodelofacuteinflammation.Br.J.Pharmacol.143247PMID:15313881Petitetetal(1998)Complexpharmacologyofnaturalcannabinoids:evidenceforpartialagonistactivityofΔ9-tetrahydrocannabinolandantagonistactivityofcannabidiolonratbraincannabinoidreceptors.LifeSci.63PL1PMID:9667767Rybergetal(2007)TheorphanreceptorGPR55isanovelcannabinoidreceptor.Br.J.Pharmacol.1521092PMID:17876302Thomasetal(2007)CannabidioldisplaysunexpectedlyhighpotencyasanantagonistofCB1andCB2receptoragonistsinvitro.Br.J.Pharmacol.150613PMID:17245363Keywords:(-)-Cannabidiol,supplier,Natural,cannabinoids,AMT,inhibitors,inhibits,GPR55,antagonists,weak,CB1,CB2,inverse,agonists,Anandamide,Transporters,Monoamine,Neurotransmitter,Non-Selective,Receptors,cb2r,cb1r,CBD,Cannabinoid,Transporters,Non-selective,Cannabinoids,Non-selective,Cannabinoids,TocrisBioscience
Tocris Bioscience是一家专卖生命科学研究chemicals, peptides and antibodies的知名品牌,其产品也广为各大药厂、大学、研究机构,超过五万名科学研究者所采用。 目前,產品內容已超過一千六百種以上,並每年持續不斷的增加新的產品。目前,产品内容已超过一千六百种以上,并每年持续不断的增加新的产品。
Tocris bioscience是位于英国布里斯托尔(Bristol)的高品质试剂提供商,共有2000多种产品,主要集中在神经科学和信号传导领域,产品类型包括小分子、多肽、抗体、配体和化合物筛选文库等,主要产品包括GPCR ligands,神经传递素,离子通道调控剂,信号通路抑制剂等,这些产品被广泛选择性地用于阻断或激活生物学通路。Tocris是世界上神经科学研究领域无可争议的领导者,其生产的影响神经系统的化学物质被多次引用,这些物质很多都来自Jeff Watkins(Tocris 的创立人)在Bristol大学原创性的研究工作。
Tocris Bioscience的主要产品包括:
Small Molecules
Peptides
Aptamers
Controlled Substances
Compound Libraries
DREADD Ligands
Fluorescent Imaging
Ligand Sets
Optopharmacology
Reagents
Toxins
按照研究领域细分:
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System